H Saitoh

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

Yasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi et al. · Blood · 2009 · 208 citations

Life Sciences, Molecular Genetics, Oncology +17

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia

Naoto Takahashi, Masatomo Miura, Stuart A. Scott et al. · Journal of Human Genetics · 2010 · 163 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +14

Skewed T cell receptor repertoire of Vδ1+ γδ T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein–Barr virus-infected B cells in clonal restriction

Naohito Fujishima, Mitsuyoshi Hirokawa, Masumi Fujishima et al. · Clinical & Experimental Immunology · 2007 · 82 citations · Full text

Life Sciences, Hematology, Immunology +14

Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.

K. Takeyama, Masashi Seto, Naokuni Uike et al. · PubMed · 2000 · 67 citations

Medicine, Hematology, Oncology +17

FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.

A Kanamaru, Y Takemoto, Eizo Kakishita et al. · PubMed · 1995 · 54 citations

Pharmacy, Immunology, Pharmacotherapy +17